NSAM
AZN icon

North Star Asset Management’s AstraZeneca AZN Stock Holding History

North Star Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$504K Hold
2,656
– – 0.02% 251
2026
Q1 		$524K Sell
2,656
-1
-0% -$193 0.02% 246
2025
Q4 		$489K Hold
2,657
– – 0.02% 244
2025
Q3 		$408K Buy
2,657
+507
+24% +$76.7K 0.02% 250
2025
Q2 		$300K Buy
+2,150
New +$301K 0.01% 276

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

North Star Asset Management's AZN Position: Q2 2026 in Review

North Star Asset Management held its AstraZeneca (AZN) position steady in Q2 2026 at 2,656 shares worth $504K. The position accounts for 0.02% of the portfolio, ranked #251.

North Star Asset Management first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $524K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • North Star Asset Management held 2,656 shares of AstraZeneca worth $504K as of Q2 2026.
  • North Star Asset Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.02% of North Star Asset Management's portfolio in Q2 2026, its #251 holding.
  • North Star Asset Management first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • North Star Asset Management's AstraZeneca position peaked at $524K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.